Complementary treatment and markers in inflammatory bowel diseases
Abstract
Complementary Treatment and Markers in Inflammatory Bowel Diseases
Maria Pagoldh
Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Aims: The aims of this thesis were to evaluate potential prognostic markers and addition of complementary treatments in inflammatory bowel diseases.
Background: Inflammatory bowel diseases, the two main types of which are ulcerative colitis and Crohn’s disease, affect nearly 1% of the Scandinavian population and implies a risk of a chronic progressive, disabling disease. When considering treatment options, issues are: pre-dicting short and long-term prognosis, selecting optimal treatment options and providing ap-propriate care for complications of the conditions or treatments.
Methods: Selected variables were investigated to determine their ability to predict colectomy in an early phase of a severe attack of ulcerative colitis in patients admitted to hospital. Hy-perbaric oxygen treatment was tested as a complementary treatment in acute severe ulcerative colitis. Addition of supplementary treatment with cereals was evaluated in patients with se-quelae after intestinal resections.
Results and Conclusions: Analyses of stool frequency, faecal weight and complement factor 3c in plasma may contribute to an early prediction of the disease course in a severe attack of ulcerative colitis. Hyperbaric oxygen treatment as a complementary treatment in a severe at-tack of ulcerative colitis does not improve clinical outcome. Specially processed cereals, as well as non-processed cereals, can be safely used in patients with previous intestinal resec-tions. Intake of non-processed cereals may decrease faecal volume in these patients.
Key words: inflammatory bowel diseases, ulcerative colitis, Crohn disease, predictor, com-plementary therapies, hyperbaric oxygen therapy
ISBN: 978-91-628-8844-2
http://hdl.handle.net/2077/34071
Gothenburg 2014
Parts of work
I. Pagoldh M et al. Faecal analysis and plasma complement factor 3c levels at admissionfor an acute attack of ulcerative colistis are predictive of the need for colectomy. Eur J Gastroenterol Hepatol. 2014 Jan 13. [Epub ahead of print] ::PMID::24418832 II. Pagoldh M et al. Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study. Scand J Gastroenterol 2013;48(9):1033-1040. Epub Jul 23. ::doi::10.3109/00365521.2013.819443 III. Pagoldh M et al. Effects of a supplementary diet with specially processed cereals in patients with short bowel syndrome. Eur J Gastroenterol Hepatol 2008;20:(11)1085-1093. ::doi::10.1097/MEG.0b013e328303c00a
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Medicine. Department of Molecular and Clinical Medicine
Disputation
Fredagen den 21 februari 2014, kl 13.00, Aulan, Centralkliniken Sahlgrenska Universitetssjukhuset/Östra sjukhuset
Date of defence
2014-02-21
maria.pagoldh@vgregion.se
Date
2014-01-31Author
Pagoldh, Maria
Keywords
inflammatory bowel diseases
ulcerative colitis
Crohn disease
predictor
complementary therapies
hyperbaric oxygen therapy
Publication type
Doctoral thesis
ISBN
978-91-628-8845-9
Language
eng